The American Journal of Surgery
Volume 200, Issue 3 , Pages 328-333 , September 2010

Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses

  • Beom Su Kim, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • ,
  • Sung Tae Oh, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • ,
  • Jeong Hwan Yook, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • ,
  • Kab Choong Kim, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • ,
  • Min Gyu Kim, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • ,
  • Jun Won Jeong, M.D.

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388–1, Pungnap 2 dong, Songpa-Gu, Seoul, 138–736, Korea
    • ,
  • Byung Sik Kim, M.D.

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82-2-3010-3491; fax: +82-2-474-9027

Received 1 July 2009 ,Revised 9 October 2009

References 

  1. Modlin IM, Lye KD, Kidd MA. 50-Year analysis of 562 gastric carcinoids: small tumor or larger problem?. Am J Gastroenterol. 2004;99:23–32
  2. Modlin IM, Lye KD, Kidd MA. 5-Decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959
  3. Godwin JD. Carcinoid tumors (An analysis of 2,837 cases). Cancer. 1975;36:560–569
  4. Bordi C. Endocrine tumours of the stomach. Pathol Res Pract. 1995;191:373–380
  5. Bordi C, Azzoni C, D'Adda T, et al. Neuroendocrine tumors of the stomach (Pathogenesis, classification and clinical aspects). Pathologe. 1997;18:313–321
  6. Rindi G, Azzoni C, La RS, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–542
  7. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20:168–172
  8. Thomas RM, Baybick JH, Elsayed AM, et al. Gastric carcinoids (An immunohistochemical and clinicopathologic study of 104 patients). Cancer. 1994;73:2053–2058
  9. Matsui K, Kitagawa M, Miwa A, et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 1991;86:1167–1175
  10. Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006
  11. Burkitt MD, Pritchard DM. Review article: pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006;24:1305–1320
  12. Borch K, Ahren B, Ahlman H, et al. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242:64–73
  13. Norton JA, Melcher ML, Gibril F, et al. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger–Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery. 2004;136:1267–1274
  14. Bordi C, Falchetti A, Azzoni C, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol. 1997;21:1075–1082
  15. Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56:455–462
  16. Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg. 1996;20:173–182
  17. Delle Fave G, Capurso G, Milione M, et al. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol. 2005;19:659–673
  18. Modlin IM, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surg Oncol. 2003;12:153–172
  19. Gilligan CJ, Lawton GP, Tang LH, et al. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995;90:338–352
  20. Ferraro G, Annibale B, Marignani M, et al. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab. 1996;81:677–683
  21. Fykse V, Sandvik AK, Qvigstad G, et al. Treatment of ECL cell carcinoids with octreotide LAR. Scand J Gastroenterol. 2004;39:621–628
  22. Hou W, Schubert ML. Treatment of gastric carcinoids. Curr Treat Options Gastroenterol. 2007;10:123–133
  23. Tomassetti P, Migliori M, Caletti GC, et al. Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med. 2000;343:551–554
  24. Solcia E, Rindi G, Larosa S, et al. Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc Res Tech. 2000;48:339–348

PII: S0002-9610(10)00089-9

doi: 10.1016/j.amjsurg.2009.10.028

The American Journal of Surgery
Volume 200, Issue 3 , Pages 328-333 , September 2010

Article Tools

* Image Usage & Resolution